Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,123.23
    +44.37 (+0.55%)
     
  • Bitcoin USD

    64,338.41
    +688.02 (+1.08%)
     
  • CMC Crypto 200

    1,389.50
    -7.03 (-0.50%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • Dow

    38,085.80
    -375.12 (-0.98%)
     
  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     
  • Gold

    2,362.10
    +19.60 (+0.84%)
     
  • Crude Oil

    84.19
    +0.62 (+0.74%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Company News For Dec 18, 2017

Is (AMTD) Outperforming Other Finance Stocks This Year?
  • Adobe Systems Incorporated’s ADBE shares increased 1.4%, after reporting fiscal fourth quarter non-GAAP earnings of $1.26 per share, beating the Zacks Consensus Estimate of $1.15

  • Shares of Costco Wholesale Corporation COST rose 3.3% after posting fiscal first quarter adjusted earnings per share of $1.36, higher than the Zacks Consensus Estimate by a cent

  • Oracle Corporation’s ORCL shares fell 3.8% after projecting fiscal third quarter adjusted earnings per share in the range of $0.68-$0.70, with the high-end of the guidance below the Zacks Consensus Estimate of $0.72

  • Shares of Global Blood Therapeutics Inc. GBT declined 8% after announcing a $100 million common stock public offering 


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Oracle Corporation (ORCL) : Free Stock Analysis Report
 
Adobe Systems Incorporated (ADBE) : Free Stock Analysis Report
 
Global Blood Therapeutics, Inc. (GBT) : Free Stock Analysis Report
 
Costco Wholesale Corporation (COST) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research